Needle-Free Devices Market by Pain Management, Vaccine Delivery, Insulin Delivery and Pediatric Drugs to 2024 - Rear Excessive Growth Estimated by Key Top Players Like 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck

Download Free PDF Brochure of Needle-Free Devices Market Research Report Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=2079086 .

Insulin delivery was most prominent application segment in needle-free drug delivery device market in 2017. The growth of the segment can be to rising incidence of diabetes and increasing shift towards unhealthy lifestyle habits. For instance, according to the Centers for Disease Control and Prevention, about 30.3 million individuals were affected by diabetes globally in 2017, of which 9.4% were U.S. citizens.

This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.

Report Includes:
- 36 data tables and 34 additional tables
- Detailed overview of the global markets for needle-free devices and technologies within the industry
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, South Korea, Middle East and Africa
- Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
- Insight into various needle-free technologies that are used in drug delivery and their various application areas
- A look at the government regulations that can affect the global needle-free devices market
- Identification of the competitive landscape of the market with the leading market players, suppliers and pharmaceutical partners

Inquire for Discount Now on Needle-Free Devices Market Report Now at
https://www.reportsnreports.com/contacts/discount.aspx?name=2079086 .

The global market for needle-free technologies was worth REDACTED in 2017. The market is expected to increase at a compound annual growth rate (CAGR) of REDACTED during the forecast period 2018-2023. Growth in this segment is being fueled by evolving market dynamics and a growing interest in safe, effective and advanced needle-free drug delivery technologies.

Major drivers of the global needle-free device market are as follows -
- Increasing incidence of needlestick injuries.
- Growing cases of needle phobia.
- Increasing demand for painless drug delivery.
- Product innovations.
- Increased prevalence of diabetes globally.
- Increasing incidence of blood-borne diseases globally.
- Public awareness of HIV/AIDS and the significance of needle-free devices in preventing HIV

At the same time, novel drug delivery technologies help retain market leadership, protect sales revenues and bring competitive value to pharmaceutical companies and technology partners. Profiles of major vendor companies, including 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck Serono S.A., and Teva Pharmaceutical Industries Ltd.

Order the Needle-Free Devices: Technologies and Global Markets Report Now at https://www.reportsnreports.com/purchase.aspx?name=2079086 .

Needle-free drug delivery devices or needle-free injections are the devices used to introduce various medicines into the human body without piercing the skin, unlike conventional needle. A tube-shaped device is held against the skin and then it is forced to release medicine which penetrates through the skin and tissues thereby enters into the bloodstream.

North America accounted for approximately 44.0% of the overall revenue in 2017. High awareness regarding potential benefits of needle-free drug delivery devices has supported the dominance of the region in the global arena. Moreover, presence of well-developed healthcare facilities and extensive R&D expenditure by government organizations and pharmaceutical companies for diabetes and chronic pain management are also contributing to the growth of the market.

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.